Cholinergic agonists and antagonists - PowerPoint PPT Presentation

1 / 60
About This Presentation
Title:

Cholinergic agonists and antagonists

Description:

Title: , Author: Last modified by: Created Date – PowerPoint PPT presentation

Number of Views:1731
Avg rating:3.0/5.0
Slides: 61
Provided by: 5009337
Category:

less

Transcript and Presenter's Notes

Title: Cholinergic agonists and antagonists


1
Cholinergic agonists and antagonists
2
(No Transcript)
3
(No Transcript)
4
  • Synapses are specialized junctions through which
    neurons signal to each other and to non-neuronal
    cells such as those in muscles or glands

5
  • Cholinergic nervous fibres are
  • 1) preganglionic (sympoathetic and
    parasypmathetic)
  • 2) all postgnglionic parasympathetic
  • 3) postganglionic sympathetic which supply sweat
    glands and vessels of skeletal muscles
  • 4) somatic nerves
  • 5) nerves which supply adrenal medulla and
    carotic sinuses
  • 6) neurons of CNS
  • Adrenergic nervous fibres are
  • 1) postganglionic sympathetic, except those
    which supply sweat glands and vessels of skeletal
    muscles
  • 2) neurons of CNS

6
  • Cholinergic drugs
  • 1) M-, N-cholinomimetics (acetylcholine,
    carbacholine)
  • 2) Anticholinesterase drugs cholinesterase
    inhibitors (proserin, galanthamine hydrobromide,
    pirydostygmine bromide, armine)
  • 3) M-, N- cholinoblockers (amisyl, cyclodol)
  • 4) M-cholinomimetics (pilocarpin, aceclidyn)
  • 5) M-cholinoblockers (atropine sulphate,
    platyphyllin hydrotartrate, scopolamine
    hydrobromide, metacinum)
  • 6) N-cholinomimetics (cytyton, lobelin)
  • 7) N-cholinoblockers ?) ganglionblockers
    (benzohexonium, pentamin, hygronium, arphonade)
    ?) myorelaxants (tubocurarinum
    chloride, dytylinum, melliktin)

7
M-, N-cholinomimetics
  • Acetylcholine
  • Carbacholine

8
  • Carbacholine
  • 0,5-1 solutions of carbacholine -
    eye drops for treatment of glaucoma
  • The drug is never used orally and with injections
    because of its consideralbe toxicity !

9
M-, N-cholinoblockers
  • Amizyl
  • Cyclodol

10
  • Amizyl
  • Indications for administration
  • neurotic disorders, Parkinson disease and other
    extrapyramidal disorders, for premedication
    before narcosis, for diseases which are
    accompanied with spasm of smooth muscles, for
    dilation of pupil in ophtalmology
  • The drug is administered orally 0,001-0,002 g
  • 3-4 times per day,
  • as eye dropps - 1-2 solution is used
  • Side effects dryness of mucous membranes,
    tachycardia, dilation of pupils, disturbances of
    accomodation.
  • The drug is contraindicated in case of glaucoma!

11
  • Cyclodol
  • Anticholinergic drug, mainly blocks central
    N-cholinoreceptors and peripheral
    M-cholinoreceptors
  • Usage
  • Park?nson disease,
  • medicamental parkinsonism

12
Anticholinesterase drugs
  • Proserinum,
  • Galanthamini hydrobromidum,
  • Armin,
  • Pirydostygmini bromidum

13
  • Proserinum
  • Proserin is an anticholinesterase drug of reverse
    action, its effect lasts for 2,5-4 hours.
  • Indications for administration
  • Impairment of nerve conduction after
    polyomyelitis, paralysis, neurities, traumas
  • overdosing with M-cholinoblockers

14
  • Galanthamini hydrobromidum
  • Duration of action of Galanthamini hydrobromidum
    is longer than of Proserinum, thats why it can
    be administered 1-2 times during the day
  • Indications for administration
  • Impairment of nerve conduction after
    polyomyelitis, paralyses, neuritis, traumas,
    overdosing with M-cholinoblockers

15
  • Pirydostigmini bromide (calimin)
  • Usage
  • myastenia gravis
  • after traumas, neuritis, paralyses
  • in a period of recovery after polyomyelitis,
    encephalitis

16
myastenia gravis
17
  • Anticholinesterase drugs are
  • contraindicated
  • in cases of epilepsia, hyperkinesias, bronchial
    asthma, stenocardia, bradycardia

18
Acute poisoning with anticholinesterase drugs
(POC)
  • nausea, vomiting, diarrhea, abdominal pain
  • quick contraction of pupils, disturbance of
    visus (spasm of accomodation)
  • increasing of salivation and sweating
  • bronchospasm
  • tachy- or bradicardia
  • seizures, excitement, loss of consciousness,
    coma
  • Death is caused by breath insufficiency,
    bronchospasm and lungs edema

19
Treatment of acute poisoning
  • Treatment should be started immediately (WHO)
  • stomach lavage with solution of Sodium
    hydrocarbonate
  • salt laxatives, enterosorbents
  • siphon enema
  • the poison should be carefully washed away from
    the skin
  • forced diuresis, in complicated cases -
    hemosorbtion, hemodialysis
  • Indication of antagonist is necessary!!!
    atropine sulphate. It should be introduced
    intravenously repeatedly, 2-4 ml of 0,1
    solution with the interval of 5-10 minutes.
    Appearance of tachycardia, dilation of pupils,
    dryness in the mouth are the criteria of
    sufficiency of atropine sulfate dose.
  • Also reactivators of cholinesterase which renew
    activity of this enzyme are administered
    dipyroxym, alloxym, isonitrosyn

20
Treatment of acute poisoning
  • Depending on severity of poisoning dipyroxym is
    introduced once or a few times. An average dose
    of the drug in heavy cases is 3-4 ml of 15
    solution. The total dose of alloxym is 0,4-1,6 g
    (0,075 g every 1-3 hours). If necessary -
    artificial ventilation should be performed to a
    patient. And after symptomatic treatment is
    carried on.

21
M-cholinergic drugs
22
  • M-cholinomimetics
  • M-cholinoblockers

23
  • M-cholinomimetics
  • Pilocarpini hydrochloridum
  • Aceclidinum

24
  • ?ilocarpini hydrochloridum
  • Pharmacodinamics
  • Contraction of pupil, improvement of outflow of
    intraocular liquid and relief intraocular
    pressure
  • Dilation of eye vessels
  • Usage
  • Treatment of glaucoma
  • Improvement of eye nutrition in a case of
    thrombosis of retinal central vein, acute
    obstruction of retinal arteries, optic nerve
    atrophy
  • Systemic (resorbtive) action of the drug is not
    used because of its high toxicity. The most
    dangerous manifestation of poisoning with
    pilocarpinum is edema of lungs

25
  • Aceclidinum
  • Pharmacodinamics
  • Miosis, decrease of intraocular pressure, spasm
    of accomodation
  • Increase of tonus and peristalsis of smooth
    muscles of digestive tract organs, urinary
    bladder
  • Increase of tonus of uterus and bronchial
    muscles
  • Usage
  • treatment of glaucoma
  • prophylaxis and treatment of postoperative atony
    of stomach, intestines, urinary bladder
  • stopping of post delivery uterus bleedings
  • The drug is contraindicated in case of bronchial
    asthma, pregnancy, stenocardia

26
Acute poisoning with substances of
M-cholinomimetic action (overdosing of drugs,
consumption of mushrooms of Inocibe family)
  • Clinical signes
  • diarrhea, stomachache
  • contraction of pupils, disorders of accomodation
  • increasing of salivation, vomiting
  • disorders of breathing because of bronchial
    spasm
  • confusion, consciousness, seizures, coma
  • Treatment
  • measures for organism purifying form poison
  • intravenous introduction of 0,1 Atropine
    sulfate solution 2 ml every 10 min. (until
    appearance of dryness in mouth and dilation of
    pupils)
  • symptomatic treatment

27
  • M-cholinoblockers
  • Atropine sulfate
  • Scopolamine hydrobromide
  • Platyphyllin hydrotartrate
  • Metacinum
  • Dry extract of Belladonna

28
Pharmacokinetics and usage of M-cholinoblockers
  • Influence on an eye
  • Dilation of a pupil (midriasis)
  • Increasing of intraocular pressure
  • Paralysis of accomodation (cycloplegia)
  • Midriasis and cycloplegia stay for atropine
    7-11 days, gomatropine 1-2 days, platyphyllin
    5-6 hours,
  • scopolamine 4-5 days
  • Usage
  • Investigation of orbital fundum (posterior
    chamber of eye)
  • Prevention of synechia (comissures) in case of
    trauma and operations on eye
  • Contraindication
  • glaucoma

29
Pharmacodynamics and usage of
M-cholinoblockers
  • Pharmacodynamics
  • Decreasing of function of excretory glands,
    except mammal glands
  • Decreasing of tonus and peristalsis of smooth
    muscles of digestive tract, bronchi, urinary
    tracts
  • Usage
  • Ulcer disease of stomach and duodenum
    (gastrocepin)
  • Liver, renal, intestinal colics
  • Dyskinesias of gastrointestinal tract, enteritis,
    colitis
  • Cystitis
  • Bronchial spasm (Ipratropii bromide - atrovent)

30
Other cases of M-cholinoblockers administration
  • Holding of atropine test in case of
    atrioventricular blockade (atropine)
  • In anesthesiologia for premedicatoin for
    prevention of bronchial and laryngeal spasm,
    syncope, limitation of salivary and bronchial
    glands secretion (atropine, scopolamine,
    metacinum)
  • Poisoning with M-cholinomimetics and POC
    (atropine)
  • Sea, air disease (scopolamine, aeronum)

31
Gastrozepin (Gastrocepinum)
32
Side effects of M-chlinoblockers
  • Dryness of mucous membranes, dysphagia, dysphonia
  • Tachycardia
  • Increasing of intraocular pressure, glaucoma
    attack
  • Constipation, retention of urine (ischuria)
  • Formation of bronchial plugs in patients with
    bronchial asthma
  • Overheating
  • M-cholinoblockers are absolutely contraindicated
    in patients with glaucoma

33
Acute poisoning with substances of
M-cholinoblocking action
  • Causes
  • Overdosing with drugs of
    M-cholinoblockers group
  • Consumption of plants, which include alcaloids of
    this group

34
Belladonna
35
Datura stramonium L
36
Symptoms of acute poisoning with M-cholinoblockers
  • Atropine psychosis delirium, hallucinations,
    disorientation, psychomotor excitement
  • Redness and dryness of skin, increasing of body
    temperature
  • Dryness of mucous membranes causes disorders of
    swallowing (dysphagia), speech (dysartria,
    raleness of voice)
  • Thirst
  • Quick dilation of pupils (midriasis)
  • Photophobia
  • Visus disorders (Paralysis of accomodation)
  • Tachycardia
  • Atony of intestines
  • Retention of urine
  • Death is caused by paralysis of breath center

37
TREATMENT OF ACUTE POISONING WITH
M-CHOLINOBLOCKERS
  • wash out of stomach with 0,5 Tannin solution,
    laxative agents, sorbents, forced diuresis
  • Specific antagonists anticholinesterase drugs
    repeated introduction of proserinum,
    galantaminum, hydrobromidum until symptoms of
    disappearance of M-cholinoblockers blockade
  • removal of psychomotor excitement - aminasinum,
    sybazon, barbiturates
  • removal of tachycardia anapryline
  • for relief of photophobia patient is transferred
    to a dark room
  • for decreasing of body temperature ice-cube
    bottles are placed around the patient
  • In case of considerable depressing of breathing
    - artificial ventilation with oxygen inhalation

38
N-cholinergic drugs
39
  • N-cholinomimetics
  • Cytitone
  • Lobeline hydrochloride

40
  • Cytitone
  • Pharmacodynamics
  • increases tone of respiratory center of medulla
    oblongata reflectively
  • increases arterial pressure due to reflective
    excitation of vascular-motor center
  • Usage
  • respiratory arrest due to inhalation of
    irritative substances,
  • traumas, electro-shock, surgical operations
  • morphine and CO poisoning
  • shock and collapse conditions, depression of
    blood circulation and breathing in patients with
    infectious diseases

41
  • Lobeline is a natural alkaloid found in "Indian
    tobacco" (Lobelia inflata)
  • Usage Breath stop of reflex origin
  • Lobeline has been used as a smoking cessation
    aid, and may have application in the treatment of
    other drug addictions such as addiction to
    amphetamines, cocaine or alcohol.

42
Acute poisoning with nicotine
  • Clinical picture
  • nausea, vomiting, salivation,
  • abdominal pain, diarrhea,
  • dizziness,
  • headache,
  • cold sweat, weakness,
  • loosing of consciousness,
  • tachy- or bradycardia,
  • cardiac arrhythmias,
  • seizures,
  • breathing depression
  • Death is caused by acute depression of
    respiratory center and paralysis of breathing
    musculature

43
(No Transcript)
44
Chronic poisoning with nicotine
  • Chronic diseases of respiratory system,
  • Lung cancer,
  • Malignant tumors of other etiology,
  • Ischemic heart disease,
  • Obliterating endarteritis,
  • Gastric and duodenal ulcer disease
  • Women
  • Depression of female sex hormones production,
    yellow face, early wrinkles, damaging of teeth,
    harsh voice, sometimes male type hair growth
  • Men
  • Deep, irreversible changes of spermatozoids

45
  • N-cholinoblockers
  • Ganglionblockers
  • Benzohexonium, pentamin, hygronium, arphonad
  • Myorelaxants
  • Tubocurarine chloride, dithylin, mellictin

46
  • Ganglionblockers

47
  • PHARMACODYNAMICS
  • Dilation of peripheral vessels
  • Decreasing of blood pressure
  • Decreasing of smooth muscle tone of inner organs
    (bronchi, GI tract, urinary and bile tracts)
  • Decreasing of gland secretion bronchial,
    gastric, salivary

48
  • Benzohexonium
  • Does nor penetrate through blood-brain barrier
  • Duration of action varies from 3 to 6 hours
  • Usage
  • Hypertensive crisis
  • Obliterating endarteritis
  • Spasm of peripheral vessels
  • Intestinal, hepatic, kidney colic
  • Gastric ulcer
  • Bronchial asthma, lung emphysema, lung edema

49
  • Pentaminum
  • Duration of action 2-4 hours
  • Usage
  • Hypertensive crisis
  • Obliterating endarteritis
  • Spasm of peripheral vessels
  • Intestinal, hepatic, kidney colic
  • Gastric ulcer
  • Bronchial asthma, lung emphysema

50
  • Hygronium
  • Effect develops after 2-3 min, and lasts for
    10-15 min after stopping of infusion
  • Usage
  • For controlled hypotonic
  • For treatment of nephropathy and eclampsia
  • For complex therapy of hypertensive crisis, brain
    edema, lung edema

51
  • Pirilenum
  • Penetrates through blood-brain barrier and blocks
    central N-cholinergic systems
  • Effect is observed after 1-2 hours and lasts
    for 6-8 hours if administered orally
  • Usage
  • Heavy form of arterial hypertension
  • Trophic disorders

52
  • Side effects and complications
  • of ganglionblockers
  • Orthostatic collapse (postural hypotension)
  • Dryness of mucous membranes
  • Disturbance of accommodation
  • General weakness
  • Dizziness
  • Tachycardia
  • Atonia of urinary bladder, intestines (paralytic
    ileus)

53
  • Myorelaxants

54
  • Antidepolarizing type of action (pachicurare)
  • Tubocurarine chloride, anatruxonium, pipecuronium
    bromide, mellictin
  • Depolarizing type of action (leptocurare)
  • dithylinum

55
  • Skeletal muscles relax in such turn
  • Small muscles of fingers,toes, ears, eyes, head,
    neck, muscles of extremities, trunk,
  • Intercostals muscles and diaphragm
  • Restoring of tone is performed in reversed
    sequence

56
(No Transcript)
57
  • Tubocurarine chloride
  • Relaxation begins after 1-1,5 min after
    introduction and lasts for 25-40 min
  • Usage
  • For prolonged relaxation of striped muscles
    during surgical operations
  • For relaxation of muscles while repositioning
    fractured bones and complicated dislocations
  • For prevention of traumatic injuries during
    seizure therapy of schizophrenia, during
    epileptic status, seizures of other etiology
  • PROSERINE is introduced
  • to overcome action of the drug

58
  • Dithylinum
  • (suxamethonium, succinilcholin, listenon)
  • Miorelaxation develops after 40-60 sec. Total
    reviving of muscle tone comes after 5-10 min.
  • Usage
  • before such manipulations as tracheal
    intubation, broncho- and esophagoscopia,
    cystoscopia
  • for reposition of fractures bones, dislocations

59
Insufficiency of buthyrilcholinesterase
(genetic pathology)
  • In this pathology action of dithylinum can last
    for several hours, and all this time the patient
    should be connected to artificial respiration
    device
  • TREATMENT
  • Introduction of fresh-citrate blood
  • Direct blood infusion from donnor
  • Introduction of buthyrilcholinesterase

60
  • Mellictine
  • Usage
  • For disease and syndrome of Parkinson,
    postencephalitic parkinsonism,
  • spinal arachnoiditis,
  • arachnoencephalitis
  • All myorelaxants are contraindicated for
    patients with myasthenia
Write a Comment
User Comments (0)
About PowerShow.com